Colgate-Palmolive (CL) Projected to Post Earnings on Friday

Colgate-Palmolive (NYSE:CL) is projected to release its Q2 2025 earnings data before the market opens on Friday, August 1st. Analysts expect Colgate-Palmolive to post earnings of $0.88 per share and revenue of $5.03 billion for the quarter.

Colgate-Palmolive Trading Down 1.3%

Colgate-Palmolive stock opened at $85.76 on Thursday. The firm’s 50-day moving average is $89.91 and its 200-day moving average is $90.33. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. Colgate-Palmolive has a 1 year low of $85.32 and a 1 year high of $109.30. The company has a market cap of $69.50 billion, a P/E ratio of 24.23, a PEG ratio of 4.48 and a beta of 0.37.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.43%. Colgate-Palmolive’s payout ratio is currently 58.76%.

Hedge Funds Weigh In On Colgate-Palmolive

A hedge fund recently raised its stake in Colgate-Palmolive stock. Woodline Partners LP grew its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 76.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 46,361 shares of the company’s stock after purchasing an additional 20,062 shares during the period. Woodline Partners LP’s holdings in Colgate-Palmolive were worth $4,344,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently issued reports on CL. Barclays raised their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 15th. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $103.00 to $99.00 and set an “overweight” rating on the stock in a research report on Friday, July 25th. Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “underweight” rating in a report on Wednesday, April 2nd. Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a “buy” rating in a report on Monday, April 28th. Finally, Wall Street Zen cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Wednesday, May 7th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $100.58.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.